Suppr超能文献

重症急性呼吸综合征患者血清细胞因子分析

Analysis of serum cytokines in patients with severe acute respiratory syndrome.

作者信息

Zhang Yuanchun, Li Jing, Zhan Yuliang, Wu Lianqiu, Yu Xueying, Zhang Wenjian, Ye Liya, Xu Shiqing, Sun Ruihua, Wang Yunting, Lou Jinning

机构信息

Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, People's Republic of China.

出版信息

Infect Immun. 2004 Aug;72(8):4410-5. doi: 10.1128/IAI.72.8.4410-4415.2004.

Abstract

Severe acute respiratory syndrome (SARS) is an acute infectious disease of the respiratory system. Although a novel coronavirus has been identified as the causative agent of SARS, the pathogenic mechanisms of SARS are not understood. In this study, sera were collected from healthy donors, patients with SARS, patients with severe SARS, and patients with SARS in convalescence. The serum concentrations of interleukin-1 (IL-1), IL-4, IL-6, IL-8, IL-10, tumor growth factor beta (TGF-beta), tumor necrosis factor alpha (TNF-alpha), and gamma interferon (IFN-gamma) were measured by enzyme-linked immunosorbent assays (ELISA). The concentrations of IL-1 and TNF-alpha were not significantly different in different groups. The IL-6 concentration was increased in SARS patients and was significantly elevated in severe SARS patients, but the IL-6 concentrations were similar in convalescent patients and control subjects, suggesting that there was a positive relationship between the serum IL-6 concentration and SARS severity. The concentrations of IL-8 and TGF-beta were decreased in SARS patients and significantly reduced in severe SARS patients, but they were comparable in convalescent SARS patients and control subjects, suggesting that there was a negative relationship between the IL-8 and TGF-beta concentrations and SARS severity. The concentrations of IFN-gamma, IL-4, and IL-10 showed significant changes only in convalescent SARS patients. The IFN-gamma and IL-4 levels were decreased, while the levels of IL-10 were increased, and the differences between convalescent SARS patients and other patient groups were statistically significant. These results suggest that there are different immunoregulatory events during and after SARS and may contribute to our understanding of the pathogenesis of this syndrome.

摘要

严重急性呼吸综合征(SARS)是一种急性呼吸系统传染病。尽管一种新型冠状病毒已被确定为SARS的病原体,但SARS的致病机制尚不清楚。在本研究中,收集了健康供体、SARS患者、重症SARS患者以及SARS恢复期患者的血清。通过酶联免疫吸附测定(ELISA)检测白细胞介素-1(IL-1)、IL-4、IL-6、IL-8、IL-10、肿瘤生长因子β(TGF-β)、肿瘤坏死因子α(TNF-α)和γ干扰素(IFN-γ)的血清浓度。不同组中IL-1和TNF-α的浓度无显著差异。SARS患者的IL-6浓度升高,重症SARS患者中显著升高,但恢复期患者和对照受试者的IL-6浓度相似,这表明血清IL-6浓度与SARS严重程度呈正相关。SARS患者中IL-8和TGF-β的浓度降低,重症SARS患者中显著降低,但恢复期SARS患者和对照受试者的浓度相当,这表明IL-8和TGF-β浓度与SARS严重程度呈负相关。IFN-γ、IL-4和IL-10的浓度仅在SARS恢复期患者中出现显著变化。IFN-γ和IL-4水平降低,而IL-10水平升高,SARS恢复期患者与其他患者组之间的差异具有统计学意义。这些结果表明,SARS期间和之后存在不同的免疫调节事件,可能有助于我们理解该综合征的发病机制。

相似文献

1
Analysis of serum cytokines in patients with severe acute respiratory syndrome.
Infect Immun. 2004 Aug;72(8):4410-5. doi: 10.1128/IAI.72.8.4410-4415.2004.
6
Analysis of cytokines in SARS-CoV-2 or COVID-19 patients in Erbil city, Kurdistan Region of Iraq.
PLoS One. 2021 Apr 29;16(4):e0250330. doi: 10.1371/journal.pone.0250330. eCollection 2021.
8
Interindividual variations in cytokine levels following cardiopulmonary bypass.
Heart Vessels. 1997;12(3):119-27. doi: 10.1007/BF02767129.

引用本文的文献

1
Harnessing immunotherapeutic molecules and diagnostic biomarkers as human-derived adjuvants for MERS-CoV vaccine development.
Front Immunol. 2025 Mar 13;16:1538301. doi: 10.3389/fimmu.2025.1538301. eCollection 2025.
2
RNA Viruses, Toll-Like Receptors, and Cytokines: The Perfect Storm?
J Innate Immun. 2025;17(1):126-153. doi: 10.1159/000543608. Epub 2025 Jan 16.
4
Dengue and SARS-CoV-2 co-circulation and overlapping infections in hospitalized patients.
Front Cell Infect Microbiol. 2024 Nov 8;14:1429309. doi: 10.3389/fcimb.2024.1429309. eCollection 2024.
6
The Interplay of HIV and Long COVID in Sub-Saharan Africa: Mechanisms of Endothelial Dysfunction.
Curr Cardiol Rep. 2024 Sep;26(9):859-871. doi: 10.1007/s11886-024-02087-6. Epub 2024 Jul 3.
8
The critical impacts of cytokine storms in respiratory disorders.
Heliyon. 2024 Apr 17;10(9):e29769. doi: 10.1016/j.heliyon.2024.e29769. eCollection 2024 May 15.
9
Interleukin 6 Antagonists in Severe COVID-19 Disease: Cardiovascular and Respiratory Outcomes.
Protein Pept Lett. 2024;31(3):178-191. doi: 10.2174/0109298665266730240118054023.
10
SARS-CoV-2 infection activating a novel variant of the gene and subsequently causing development of CADASIL.
Arch Med Sci. 2022 Apr 4;19(6):1781-1794. doi: 10.5114/aoms/146978. eCollection 2023.

本文引用的文献

1
Increased IL-6 and TGF-beta1 concentrations in bronchoalveolar lavage fluid associated with thoracic radiotherapy.
Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):758-67. doi: 10.1016/S0360-3016(03)01614-6.
3
Inflammatory cytokine profile in children with severe acute respiratory syndrome.
Pediatrics. 2004 Jan;113(1 Pt 1):e7-14. doi: 10.1542/peds.113.1.e7.
4
Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis.
FASEB J. 2004 Feb;18(2):370-2. doi: 10.1096/fj.03-0708fje. Epub 2003 Dec 19.
6
Lung pathology of fatal severe acute respiratory syndrome.
Lancet. 2003 May 24;361(9371):1773-8. doi: 10.1016/s0140-6736(03)13413-7.
7
A novel coronavirus associated with severe acute respiratory syndrome.
N Engl J Med. 2003 May 15;348(20):1953-66. doi: 10.1056/NEJMoa030781. Epub 2003 Apr 10.
8
Identification of a novel coronavirus in patients with severe acute respiratory syndrome.
N Engl J Med. 2003 May 15;348(20):1967-76. doi: 10.1056/NEJMoa030747. Epub 2003 Apr 10.
10
Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome.
Crit Care Med. 2003 Apr;31(4 Suppl):S258-64. doi: 10.1097/01.CCM.0000057901.92381.75.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验